Peters, K.E.; Xu, J.; Bringans, S.D.; Davis, W.A.; Davis, T.M.E.; Hansen, M.K.; Lipscombe, R.J.
PromarkerD Predicts Renal Function Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS). J. Clin. Med. 2020, 9, 3212.
https://doi.org/10.3390/jcm9103212
AMA Style
Peters KE, Xu J, Bringans SD, Davis WA, Davis TME, Hansen MK, Lipscombe RJ.
PromarkerD Predicts Renal Function Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS). Journal of Clinical Medicine. 2020; 9(10):3212.
https://doi.org/10.3390/jcm9103212
Chicago/Turabian Style
Peters, Kirsten E., Jialin Xu, Scott D. Bringans, Wendy A. Davis, Timothy M.E. Davis, Michael K. Hansen, and Richard J. Lipscombe.
2020. "PromarkerD Predicts Renal Function Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS)" Journal of Clinical Medicine 9, no. 10: 3212.
https://doi.org/10.3390/jcm9103212
APA Style
Peters, K. E., Xu, J., Bringans, S. D., Davis, W. A., Davis, T. M. E., Hansen, M. K., & Lipscombe, R. J.
(2020). PromarkerD Predicts Renal Function Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS). Journal of Clinical Medicine, 9(10), 3212.
https://doi.org/10.3390/jcm9103212